These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 20958900)
1. Use of oral ketamine in a patient with systemic mastocytosis. Yoong J; Le B Intern Med J; 2010 Oct; 40(10):735-6. PubMed ID: 20958900 [No Abstract] [Full Text] [Related]
2. Systemic mastocytosis - the importance of looking within bone marrow fragments: AJH Educational Material. Bain BJ; Khoder A; Milojkovic D; Bernard T Am J Hematol; 2014 Jan; 89(1):109-10. PubMed ID: 24123109 [No Abstract] [Full Text] [Related]
3. Lenalidomide therapy in systemic mastocytosis. Kluin-Nelemans HC; Ferenc V; van Doormaal JJ; van Iperen C; Peters WG; Akin C; Valent P Leuk Res; 2009 Mar; 33(3):e19-22. PubMed ID: 18644623 [No Abstract] [Full Text] [Related]
4. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis. Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795 [TBL] [Abstract][Full Text] [Related]
12. [Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital]. Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G Lakartidningen; 2008 Nov 12-18; 105(46):3341-4, 3346-7. PubMed ID: 19062626 [No Abstract] [Full Text] [Related]
14. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine. Angus J; Leach IH; Grant J; Ravenscroft JC Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456 [TBL] [Abstract][Full Text] [Related]
15. Aggressive systemic mastocytosis: is there a role for trisomy 8? Callera F; Chauffaille Mde L Leuk Res; 2005 Apr; 29(4):471-3. PubMed ID: 15725484 [No Abstract] [Full Text] [Related]
16. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Krauth MT; Födinger M; Rebuzzi L; Greul R; Chott A; Valent P Haematologica; 2007 Dec; 92(12):e126-9. PubMed ID: 18055976 [No Abstract] [Full Text] [Related]
17. Midostaurin (Rydapt) for AML and advanced systemic mastocytosis. Med Lett Drugs Ther; 2017 Aug; 59(1527):e140. PubMed ID: 28787746 [No Abstract] [Full Text] [Related]
18. Current approaches to the diagnosis and treatment of systemic mastocytosis. Bains SN; Hsieh FH Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640 [TBL] [Abstract][Full Text] [Related]
20. Case report: pathologic long bone fracture in a patient with systemic mastocytosis. King JJ; Crawford EA; Iwenofu OH; Fox EJ Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]